Neurology Medical News about anticonvulsant drugs; substitution

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Substitution of anticonvulsant drugs
Therapeutics and Clinical Risk Management, 06/23/09

Steinhoff BJ et al. - This paper reviews currently available literature, based on which the authors suggest that the decision to substitute should be made on an individual basis by the physician and an informed patient. Unendorsed or undisclosed substitution at the pharmacy level should be discouraged.

<< Previous
Comparison of neuropathic pain and neuronal apoptosis following...

Next >>
A neural hypothesis for stress-induced headache

Bone Density of Ambulatory Adult Patients Receiving Long-term Anticonvulsant Drug Therapy
Archives of Iranian Medicine, 11/11/09 Relevance Score: 67%

Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax Sprinkle Capsules
Mylan, 10/16/09 Relevance Score: 66%

New drugs for migraine
The Journal of Headache and Pain, 10/05/09 Relevance Score: 66%

Drug Combo May Offer Best Relief for Nerve Pain
MedLinePlus, 10/01/09 Relevance Score: 66%

Severe pruritic rash, fever, and malaise
The Clinical Advisor, 11/10/09 Relevance Score: 65%